Friday, July 10, 2026

Drug profile · INN

bendamustine

bendamustine (BENDAMUSTINE EUGIA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 2
Pipeline programs 35
News articles 0
Drug details — bendamustine

Quick answer

bendamustine (BENDAMUSTINE EUGIA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN bendamustine
Brand BENDAMUSTINE EUGIA

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. ACE-CL-311 (AMPLIFY) Phase 3 · Anaxis Pharma · Previously untreated Chronic Lymphocytic Leukemia Without de
  2. ACE-LY-308 Phase 3 · Anaxis Pharma · Mantle Cell Lymphoma
  3. Bendamustine Phase 3 · HOFFMANN-LA ROCHE · Chronic Lymphocytic Leukemia
  4. Bendamustine HCl Phase 3 · Teva Pharma · Non-Hodgkin's Lymphoma
  5. Bendamustine hydrochloride Phase 3 · Teva Pharma · Non-Hodgkin Lymphoma
  6. CA073-1003 Phase 3 · Celgene · Relapsed/Refractory Follicular Lymphoma
  7. CCTL019H2301 Phase 3 · Novartis India · Adult patients with relapsed or refractory aggressive B-cell
  8. FIL_FOLL19 Phase 3 · Telethon Foundation · Follicular Lymphoma
  1. AU 2011260614

    Oral dosage forms of bendamustine and therapeutic use thereof

    Expires Wed Jan 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. AU 2011260615

    Oral dosage forms of bendamustine

    Expires Wed Jan 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is bendamustine?

bendamustine (BENDAMUSTINE EUGIA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for bendamustine?

BENDAMUSTINE EUGIA is a marketed brand name for bendamustine. Check FDA Drugs@FDA for the current US label holder and prescribing information.